Consistent with our new findings on the ability of STAT2 to inhibit STING-dependent signaling, there is a significant association between high levels of STAT2 in tumors and shorter overall survival in patients with lung adenocarcinomas (SI Appendix, Fig. S6C). This evidence concerns the gene STING1 and lung adenocarcinoma.